Frequent RPL22 mutations were discovered in T-cell acute lymphoblastic leukemia (T-ALL) [50], gastric cancer [51], and endometrial cancer as reported at the end of 2012 [52]. This evidence concerns the gene RPL22 and T-cell acute lymphoblastic leukemia.